AptaBio Therapeutics Inc Cash Flow Statement

293780 KRW56500 700.0 1.3%

6:30am

Highly Speculative, Mid Cap, Momentum Trap

Market Cap £398.0m

Enterprise Value £371.4m

Revenue £361k

Quality

Value

Momentum

StockRank™

To unlock AptaBio Therapeutics Inc's cashflow statement please upgrade your membership.

	2017	2018	2019
Period End:	2017-12-31	2018-12-31	2019-12-31
Period Length:	12M	12M	12M
Currency:	KRW	KRW	KRW

Net Income/Starting Line

Depreciation/Depletion
Amortization
Non-Cash Items
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Prepaid Expenses
Accounts Payable
Accrued Expenses
Taxes Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.